CSPC Innovation Pharmaceutical Co Ltd Class A (300765) — Cash Flow-to-Debt Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Cash Flow-to-Debt Ratio of -0.01x as of December 2025, meaning its operating cash flow of CN¥-25.98 Million could theoretically repay 0% of its total liabilities (CN¥3.48 Billion) in one year. See CSPC Innovation Pharmaceutical Co Ltd Cl free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CSPC Innovation Pharmaceutical Co Ltd Class A Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for CSPC Innovation Pharmaceutical Co Ltd Class A across 12 annual periods. Also explore CSPC Innovation Pharmaceutical Co Ltd Cl (300765) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)
Year-by-year debt coverage analysis for CSPC Innovation Pharmaceutical Co Ltd Class A. For market capitalisation and broader financial context, see how much is CSPC Innovation Pharmaceutical Co Ltd Cl worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | CN¥-195.69 Million | CN¥3.48 Billion | ▲ +93.1% |
| 2024 | -0.81x | CN¥-1.24 Billion | CN¥1.53 Billion | ▼ -273.6% |
| 2023 | 0.47x | CN¥927.24 Million | CN¥1.99 Billion | ▼ -53.4% |
| 2022 | 1.00x | CN¥640.72 Million | CN¥639.84 Million | ▲ +52.1% |
| 2021 | 0.66x | CN¥292.09 Million | CN¥443.58 Million | ▼ -49.1% |
| 2020 | 1.29x | CN¥349.07 Million | CN¥269.65 Million | ▲ +79.4% |
| 2019 | 0.72x | CN¥315.38 Million | CN¥437.06 Million | ▲ +76.8% |
| 2018 | 0.41x | CN¥159.73 Million | CN¥391.45 Million | ▲ +11265.5% |
| 2017 | 0.00x | CN¥1.30 Million | CN¥362.16 Million | ▼ -99.0% |
| 2016 | 0.35x | CN¥137.27 Million | CN¥396.66 Million | ▲ +2.0% |
| 2015 | 0.34x | CN¥112.05 Million | CN¥330.20 Million | ▲ +7.1% |
| 2014 | 0.32x | CN¥93.36 Million | CN¥294.66 Million | — |